Nature Communications (Dec 2021)

KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma

  • Alexandra D’Oto,
  • Jie Fang,
  • Hongjian Jin,
  • Beisi Xu,
  • Shivendra Singh,
  • Anoushka Mullasseril,
  • Victoria Jones,
  • Ahmed Abu-Zaid,
  • Xinyu von Buttlar,
  • Bailey Cooke,
  • Dongli Hu,
  • Jason Shohet,
  • Andrew J. Murphy,
  • Andrew M. Davidoff,
  • Jun Yang

DOI
https://doi.org/10.1038/s41467-021-27502-2
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 19

Abstract

Read online

The histone demethylase KDM6B is reported to be essential for neuroblastoma cell survival. Here the authors show that KDM6B regulates CDK4/6-pRB-E2F pathway through H3K27me3-dependent enhancer-promoter interactions in neuroblastoma.